BIOTEK

BioTek Instruments was a Vermont-based manufacturer of scientific instruments and laboratory software serving basic life-science research, biotechnology, medical research, and quality-assurance applications. The company was founded in 1968 by Dr. Norman Alpert, a physiologist associated with the University of Vermont Medical College, and George H. Luhr, an engineer who directed the college's instrumentation and model facility. BioTek initially concentrated on devices used to test and calibrate medical equipment, giving it an early position in the development of specialized measurement and laboratory instrumentation. During the 1980s, BioTek expanded into microplate readers, instruments that measure biological, chemical, or biochemical reactions conducted in multiwell plates. This product direction became central to the company's identity and commercial development. Its instruments were used in applications such as cellular analysis, drug discovery, immunoassays, genomics, protein research, and other laboratory workflows in which many samples must be measured efficiently and consistently. Over time, the company broadened its portfolio to include microplate washers, dispensers, laboratory automation equipment, and software used to operate instruments and analyze results. A significant strategic change occurred in 2002, when BioTek sold its medical-equipment testing business and focused more fully on microplate technologies and related laboratory systems. By 2013, the business described itself as offering readers, washers, dispensers, software, and automation equipment, while also developing microscopy capabilities. The company manufactured products at its headquarters in Winooski, Vermont. That site was expanded in 2009 and again in 2017, supporting production and the company's growing product and engineering activities. Leadership remained closely associated with the founding family for several decades. Briar Alpert, the son of Norman Alpert, became chief executive officer in 2001. Around 2013, BioTek employed approximately 350 people, including roughly 250 in Vermont and additional personnel supporting sales in other parts of the United States and major international markets. The company was privately held and sold its products through a combination of direct and international commercial channels. In 2019, Agilent Technologies acquired BioTek for approximately $1.165 billion. The transaction brought BioTek's instruments and software into Agilent's broader analytical, laboratory, and life-science technology portfolio. Agilent positioned the acquisition as a way to strengthen its capabilities in cost-effective analysis and qualification across a wide range of life-science applications. BioTek is therefore best understood as an established scientific-instrument brand operating within Agilent Technologies rather than as an independent publicly listed company.

BioTek began in 1968 in Vermont, where physiologist Dr. Norman Alpert and engineer George H. Luhr established a company focused on scientific and medical instrumentation. Its early products were designed to test and calibrate medical equipment. This work placed the company in a specialized segment requiring precise measurement, engineering, and laboratory reliability. In the 1980s, BioTek began developing and selling microplate readers. These instruments became the foundation of its later business. Microplate-based testing allows laboratories to process many samples in parallel, and readers can measure signals associated with chemical, biochemical, or cellular reactions. BioTek used this platform to serve basic research and applied laboratory users across life-science fields. The company subsequently developed a wider family of complementary equipment, including microplate washers, dispensers, laboratory automation systems, and software. These products enabled customers to combine measurement, sample handling, process control, and data analysis within laboratory workflows. BioTek was also developing microscopy products as its technology portfolio expanded. In 2001, Briar Alpert, the son of co-founder Norman Alpert, became chief executive officer. The following year, BioTek sold its medical-equipment testing operation and concentrated its resources on microplate technologies and associated laboratory systems. This decision sharpened the company's focus on life-science research and related quality-assurance applications. BioTek manufactured its products at its headquarters in Winooski, Vermont. The facility was expanded in 2009 and again in 2017. By 2013, the company employed about 350 people, with most of its workforce located in Vermont and additional staff supporting sales in other U.S. states and major global markets. BioTek remained privately held until Agilent Technologies acquired it in 2019 for approximately $1.165 billion. The acquisition integrated BioTek's products into Agilent's broader laboratory and analytical technology activities. Agilent described the combination as expanding access to cost-effective analysis and qualification across diverse life-science applications. BioTek consequently continued as a recognized laboratory-instrumentation brand under Agilent ownership.

• 2019

  Acquisition by Agilent Technologies

  [1]BioTeken.wikipedia.org

  Agilent Technologies acquires BioTek for approximately $1.165 billion.

• 2017

  Second headquarters expansion

  [1]BioTeken.wikipedia.org

  BioTek expands its Winooski site again as its product and operating activities grow.

• 2009

  Winooski headquarters is expanded

  [1]BioTeken.wikipedia.org

  The company's Vermont manufacturing and headquarters site undergoes an expansion.

• 2002

  Medical-equipment testing business is divested

  [1]BioTeken.wikipedia.org

  BioTek sells its original testing-device business and focuses on microplate products and related laboratory technologies.

• 2001

  Briar Alpert becomes chief executive

  [1]BioTeken.wikipedia.org

  Briar Alpert, the son of co-founder Norman Alpert, assumes the chief executive role.

• 1980

  Expansion into microplate readers

  [1]BioTeken.wikipedia.org

  BioTek begins developing and selling microplate readers, which later become the core of its product portfolio.

• 1968

  BioTek is founded in Vermont

  [1]BioTeken.wikipedia.org

  Dr. Norman Alpert and George H. Luhr establish the company to develop scientific and medical instrumentation.

Laboratory instrumentation and software for scalable, automated, and cost-conscious measurement in life-science research and related quality-assurance workflows.

• Life-science laboratory instruments · 1980

  Microplate readers

  BioTek's microplate readers measure optical or other analytical signals from samples arranged in multiwell plates. They support high-throughput workflows in areas such as cellular research, drug discovery, immunoassays, genomics, and protein analysis. The product family became the central focus of the company after it moved away from medical-equipment testing.

• Laboratory sample-handling equipment

  Microplate washers

  Microplate washers automate the removal and addition of liquid during assay preparation and processing. BioTek offered these systems as complementary equipment for laboratories using plate-based analytical methods, helping standardize repetitive washing steps and integrate them into broader research workflows.

• Laboratory sample-handling equipment

  Microplate dispensers

  BioTek's dispensers were designed to distribute reagents or other liquids across microplates with greater consistency and throughput than manual handling. They formed part of the company's broader effort to connect plate measurement with automated sample preparation and laboratory process control.

• Laboratory automation

  Laboratory automation equipment

  BioTek developed automation equipment and related systems for laboratories seeking to coordinate plate handling, liquid movement, measurement, and other repetitive procedures. These products extended the company's role beyond individual instruments toward integrated and higher-throughput research workflows.

• Scientific software

  Laboratory software

  BioTek supplied software associated with its instruments and laboratory systems. The software supported instrument control, workflow management, and interpretation or handling of experimental results, helping customers operate readers, washers, dispensers, and automation equipment as connected laboratory tools.

• Laboratory imaging

  Microscopy products

  By 2013, BioTek was developing a microscopy line to broaden its life-science instrumentation portfolio. The effort extended the brand from plate-based measurement into imaging-oriented research applications, although the available reference material does not specify the complete product range or launch chronology.

• 2019

  Agilent acquires BioTekM&A

  Background

  BioTek was a privately held supplier of microplate instruments, laboratory automation, software, and related life-science technologies.

  Action taken

  Agilent Technologies acquired BioTek for approximately $1.165 billion.

  Aftermath

  BioTek's products became part of Agilent's laboratory and life-science technology portfolio, with the acquisition intended to extend cost-effective analysis and qualification capabilities.

  Acquisition value. Approximately $1.165 billion (2019 acquisition)

  Source

• 2002

  Focus the company on microplate technologiesStrategy

  Background

  BioTek had originally made devices for testing and calibrating medical equipment, but microplate readers and related life-science products had become increasingly important to its business.

  Action taken

  The company sold its medical-equipment testing business and concentrated on microplate readers, washers, dispensers, software, and laboratory automation.

  Aftermath

  The divestiture sharpened BioTek's identity as a life-science instrumentation company and supported expansion into complementary plate-based laboratory technologies.

  Source

1. 1BioTeken.wikipedia.org